Search Results - "National Institute of Epidemiology"

Effectiveness of Training for Teachers in Early Identification of Skin Disorders Among Primary School Attending Children - A Quasi-Experimental Study Protocol by Nirmaladevi Palanivel, Sunitha Kandasamy, Sangeetha Sundararaju, Padmavathi Subbiah, Abirami Govindraj, Muthu Gopal, Yuvaraj Jeyaraman, Shantaraman Kalyanaraman

Connect to this object online.

Emergence of Schoengastiella ligula as the vector of scrub typhus outbreak in Darjeeling: Has Leptotrombidium deliense been replaced? by Rina Tilak, Rajesh Kunwar, Urmila B Wankhade, V W Tilak

Connect to this object online.

Seven years of the field epidemiology training programme (FETP) at Chennai, Tamil Nadu, India: an internal evaluation by Bhatnagar Tarun, Gupte Mohan D, Hutin Yvan J, Kaur Prabhdeep, Kumaraswami Vasanthapuram, Manickam Ponnaiah, Murhekar Manoj, Ramachandran Vidya, Ramakrishnan Ramachandran

Connect to this object online.

Entry and initial spread of COVID-19 in India: Epidemiological analysis of media surveillance data, India, 2020 by Nuzrath Jahan, Polani Rubeshkumar, Mathan Karuppiah, Irene Sambath, Muthappan Sendhilkumar, Kumaravel Ilangovan, Roopavathi Ongesh, Manikandanesan Sakthivel, Raju Mohankumar, Muthusamy Santhosh kumar, Parasuraman Ganeshkumar, Manickam Ponnaiah, Prabhdeep Kaur

Connect to this object online.

Lessons learnt in implementing a pilot community event-based surveillance system in Tiruvallur district, Tamil Nadu, India by Prabhdeep Kaur, Manoj Murhekar, Jeromie Wesley Vivian Thangaraj, Muthuperumal Prakash, K.G. Kolandaswamy, Premkumar Balasubramanian, Prabhakaran Jesudoss, Krishnaraj Karupasamy, Velmurugan Ganesh, Ganesh Parasuraman, Viduthalai Virumbi Balagurusamy, Vettrichelvan Venkatasamy, Kayla F Laserson, S. Arunmozhi Balajee

Connect to this object online.

Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach by Bagepally BS, Kumar S S, Sasidharan A

Connect to this object online.

Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective by Bagepally BS, Chaikledkaew U, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A

Connect to this object online.